Braskem Confirms Restructuring Talks Ongoing as November 12 Deadline Nears
BAK sits 48% above its 52-week low of $0.743 on light trading volume (0.2× avg).
Summary
Braskem told Brazil's CVM that restructuring negotiations with creditors are still ongoing and the agreement-in-principle deadline is now November 12, 2026, without confirming reports that shareholders withdrew their capital injection.
Key Events · Legal and Risk Events · BAK
-
CVM Clarification on Restructuring Reports
Braskem responded to CVM Official Letter No. 296/2026/SEP/GEA-1 over November 7-8 press reports that shareholders withdrew a capital injection and that talks with creditors deteriorated, without confirming the reports.
-
Agreement Deadline Extended to November 12
The deadline for an agreement in principle on the Updated Plan's commercial terms was extended to November 12, 2026, since November 11, 2026 is not a business day under clauses 1.1.37 and 1.2.7 of the Plan.
-
Judicial Reorganization Remains the Fallback
Management said it will evaluate appropriate measures if no agreement on the Restructuring is reached by the deadline; the extrajudicial plan covers R$187.07 billion in debt with 39.6% signatory creditor support.
-
Prior Disclosures Reiterated
The company pointed back to its September 26, 2025, June 25, 2026 and August 24, 2026 Material Facts, plus its September 25 and October 27, 2026 responses to B3 letters.
Analysis · BAK · Industrial Applications And Services
Braskem answered a CVM request to clarify press reports that shareholders pulled a capital-injection proposal and that talks with creditors stalled. The company did not confirm the reports; it restated that negotiations over the Updated Plan continue and that the agreement-in-principle deadline has been pushed to November 12, 2026. That deadline is the pivot: a deal keeps the out-of-court restructuring on track, while a miss pushes Braskem toward a judicial reorganization filing, a materially worse outcome for equity holders given the R$187.07 billion debt load already under the extrajudicial plan.
How filings like this one have moved
In the 30 days to Nov 12, 2026, 37% of the 3595 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, BAK was trading at $1.10 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $462.8M. The 52-week trading range was $0.74 to $5.40. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.